Edwards Lifesciences Aktie

63,94 EUR +0,10 EUR +0,16 %

17:35:40

XETRA

75,08 USD +0,41 USD +0,55 %

19:06:00

BTT

Edwards Lifesciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.37,27 Mrd. EUR

KGV50,73Div. Rendite0,00%

WKN936853

ISINUS28176E1082

SymbolEW

Edwards Lifesciences Aktien News

Sortieren:Datum Meistgelesen

03.12.24PR NewswireLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Edwards Lifesciences Corporation(EW) Shareholders

27.11.24BenzingaThe Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts

14.11.24PR NewswireShareholders of Edwards Lifesciences Corporation Should Contact The Gross Law Firm Before December 13, 2024 to Discuss Your Rights - EW

13.11.24PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm

12.11.24PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit

12.11.24PR NewswireInvestors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your Rights - EW

08.11.24PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm

07.11.24PR NewswireThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 13, 2024 in Edwards Lawsuit - EW

29.10.24PR NewswireEW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

28.10.24PR NewswireEW INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

28.10.24PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm

28.10.24ZacksInternational Markets and Edwards Lifesciences (EW): A Deep Dive for Investors

28.10.24PR NewswireThe Gross Law Firm Notifies Shareholders of Edwards Lifesciences Corporation(EW) of a Class Action Lawsuit and an Upcoming Deadline

27.10.24PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit

25.10.24BenzingaCracking The Code: Understanding Analyst Reviews For Edwards Lifesciences

25.10.24ZacksCompared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics

24.10.24BenzingaUnpacking the Latest Options Trading Trends in Edwards Lifesciences

23.10.24PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit

21.10.24ZacksEdwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

21.10.24PR NewswireEW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm

17.10.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Edwards Lifesciences Corporation - EW

17.10.24BusinesswireEdwards Lifesciences to Host Earnings Conference Call on October 24, 2024

16.10.24ZacksEdwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q3 Release

14.10.24ZacksEdwards Lifesciences to Report Q3 Earnings: What's in the Cards?

01.10.24BenzingaA Closer Look at 25 Analyst Recommendations For Edwards Lifesciences

28.09.24PR NewswireONE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR ENDOTRONIX CORDELLA PULMONARY ARTERY SENSOR SYSTEM

21.08.24BusinesswireEdwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference

24.07.24BusinesswireEdwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

17.07.24BusinesswireEdwards Lifesciences to Host Earnings Conference Call on July 24, 2024

03.06.24PR NewswireBD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader

18.04.24BusinesswireEdwards Lifesciences to Host Earnings Conference Call on April 25, 2024

23.02.24BusinesswireEdwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference

30.01.24BusinesswireEdwards Lifesciences to Host Earnings Conference Call on February 6, 2024

26.10.23PR NewswireCLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION

26.10.23PR NewswireTRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION

25.10.23PR NewswireEDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

24.10.23PR NewswireFIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE

19.10.23PR NewswireEDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARK

18.10.23PR NewswireEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023

28.08.23PR NewswireEDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE

Edwards Lifesciences News

Edwards Lifesciences News: auf dieser Seite finden Sie alle Edwards Lifesciences News und Nachrichten zur Edwards Lifesciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Edwards Lifesciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Edwards Lifesciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.